Pharm. Ahmet Ozan Özgen
Business Development Executive
Custom-tailored solutions to meet and satisfy your needs.
Custom-tailored solutions to meet and satisfy your needs.
I am a Business Development executive with holistic knowledge of data management and interpretation. For each client, i can tailor feasible solutions according to their countries' local dynamics. I constantly follow developments related to my profession and interests.
I've graduated from Istanbul Medipol University Faculty of Pharmacy. 9 months of mandatory internship were included in the University's education program (throughout 5 years). I have worked 3 months in a university hospital as a clinical pharmacist, 5 months in retail pharmacies and a month in a marketing department of a pharmaceutical company. I took part as the 2nd term delegate of the Istanbul Chamber of Pharmacists Youth Council, and after graduation i continue to contribute in the Assistant Pharmacists & Youth Council commissions.
I am currently working as a business development executive with an international team and accounts from more than 20 countries in Biocalis. I am coordinating the work of my colleagues (BDRs) from Albania, Azerbaijan and Russia while directly reporting to the company CEO.
I am currently studying for my Master's Degree in Medical Biotechnology, and focused on bioinformatics to specialize in data science and programming languages.
Examples are listed below for your review and a better understanding. Also before starting, you can play this game 😸.
Services
I frequently organize and report data coming from foreign pharmaceutical markets with demand forcasting, for supply chain management, using R and Python. A study of pharmacoeconomic analysis, which titled "Pharmacoeconomic Evaluation of Biosimilars in Developing Countries" was published and presented in Pharmacology Congress, 2021.
I have been interested in pharmaceutical biotechnology since my undergraduate education, and i continue my education in this field. A research study titled "Antibiotic Susceptibility Of Klebsiella pneumoniae Strains Isolated From Clinical Samples" was published in JOTCSA and presented in National Chemical Congress, 2019, and another study's abtract named "Models of Spike, Envelope and Membrane Proteins of SARS-CoV-2 Variants for Possible Therapeutics" was published in Bio Expo, 2021.
I pay great attention to my existing accounts; adding new products to their portfolios which will be beneficial for them, evaluating their performances and providing solutions to improve their sales. Also i am constantly surveying foreign markets to find / contact potential clients to establish sustainable business models. I have general opinion on pharmaceutical markets of Balkan countries, central-asian countries and Turkish market for medical devices 1, 2, 3 .
I am experienced in planning meetings and seminars with KOLs and creating promotional / educational materials for sales team. Also i am assisting our medical sale representatives in many ways, for the medical devices of; SEBBIN (silicon body implants), Allurion (Elipse, swallowable intragastric balloon), BRVTL (bariatric dietary supplements) and Revamil (wound treatment products) 1, 2.
References
Dr. Devrim is my supervisor in Akdeniz University (Master's Degree). We are working together in studies related to in-silico research, and pharmacoeconomy.
I have met Dr. Aydın through the Clinical Research Association's (Turkey) several events and had a chance to benefit from his experiences. He is a pioneer in organizing clinical trials in Turkey.
Dr. Hasan and Dr. Devrim have been helping me as mentors by offering valuable insights within the pharmaceutical sector. We have coordinated several of our research regarding pharmacoeconomy of biologics with Dr. Devrim with the guidance of Dr. Hasan.
